| Name | Title | Contact Details |
|---|
An all-in-one fully customizable cloud-based laboratory management solution helping you manage ordering, accessioning, billing, reporting, and inventory management all with a user-friendly employer/provider portal. GoMeyra LIMS is transforming the testing industry with a system that supports operations with greater accessibility, functionality and interconnectivity. Giving labs the power to process test results with faster speeds and efficiency. Labs are able to triple capacity for same-day and give patients direct results in revolutionary times. Patients who test negative will be able to return to work and travel within 24 hours, compared to the 3-7 day quarantined wait period.
Accelerated Rehabilitation Centers is an independent, private rehabilitation practice. Physical Therapist owned with over 160 physical rehabilitation centers throughout the Midwest and Arizona.
Den-Mat Corp has also developed revolutionary LUMINEERS BY CERINATE, the first porcelain laminates that are contact lens-thin and strong, eliminating the need for the shaving and grinding down of sensitive tooth structure.
Based in Denver, Cordant Health Solutions™ provides innovative tools for monitoring and managing behavioral health, chronic pain and criminal justice cases. Our unique programs include pharmacy, clinical laboratory and analytic tools that provide actionable information to protect prescribers, improve outcomes and contain costs. As a leader in rigorous quality and compliance standards, Cordant is committed to developing groundbreaking solutions for payers, clinicians and organizations involved in the substance use disorder, criminal justice and pain management markets. Cordant offers unique risk assessment, monitoring and management tools through its integrated network of laboratories and high-touch pharmacies specializing in the management and dispensing of controlled substances and behavioral health medications. Cordant`s testing protocols and digital case-management tools help clients become more efficient and effective in assessing and managing risk, monitoring patient adherence and improving patient outcomes.
Symbiomix (sim-bye-OH-mix) is a late-stage, privately held biopharmaceutical company developing innovative medicines for serious women`s health infections that have been long neglected and are in need of new therapeutic options. Symbiomix was founded in 2012 by a team of experienced industry professionals and entrepreneurs and is backed by three of the world`s leading healthcare venture capital firms, OrbiMed, Fidelity Biosciences and HBM Partners. The Company`s lead product is SYM-1219, a novel drug candidate containing secnidazole, which is a next generation 5-nitroimidazole antibiotic. Symbiomix is based in New Jersey, with additional offices in Maryland and Connecticut.